Corcept Therapeutics | CORT - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Acadia Pharmaceuticals USD 160.79M 14.06M 2026-03
Alaunos Therapeutics USD 585K 84K 2025-09
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Ardelyx USD 75.92M 7.69M 2025-12
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Canopy Growth CAD 28.9M 636K 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Esperion Therapeutics USD 39.42M 456K 2025-12
J&J USD 6.03B 719M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Merck USD 2.67B 180M 2026-03
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novartis USD 3.14B 296M 2026-03
Novartis USD 3.44B 132M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 83.88M 7.99M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
TG Therapeutics USD 73.14M 22.42M 2026-03